Drugs and the Lung Central and Peripheral Sites of Action

  • Sheila Jennett
Part of the Ettore Majorana International Science Series book series (EMISS, volume 14)


The links between drugs and the lungs, and the distinction between central and peripheral sites of action, may be explored under three main headings:
  1. I)

    Effects of systemically administered drugs on respiratory function itself acting peripherally or centrally to alter breathing pattern, to alter ventilation, or to affect oxygen transfer.

  2. II)

    Effects of systemically administered drugs on the nonrespiratory functions of the lungs: agents acting either systemically or locally, may alter the defence functions or the metabolic functions of the lungs.

  3. III)

    Effects on the lungs themselves, or in the rest of the body, of drugs which are administered via the lungs.



Carotid Body Pulmonary Blood Flow Peripheral Site Alveolar Ventilation Extracellular Acidity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Bakhle, Y.S. (1976). The inactivation of endogenous amines in the lung. Agents Actions6, 505–509.CrossRefGoogle Scholar
  2. Borison, H.L. (1981). Central nervous respiratory depressants. In: Respiratory Pharmacology, Ed: J. Widdicombe, pp 65–83 and 751–752. Pergamon Press Oxford.Google Scholar
  3. Bradley, P.B., Briggs, I., Cayton, R.J.L.A. (1976). Effects of microiontophoretically applied methionine-enkephalin on single neurones in rat brain stem. Nature, 261, 425–426.ADSCrossRefGoogle Scholar
  4. Cooper, K.E. & Guenter, C.A. (1981). The effect on pulmonary ventilation of drugs which influence body temperature. In: Respiratory Pharmacology, Ed: J. Widdicombe. Pergamon Press, Oxford. pp. 259–267.Google Scholar
  5. Fukuda, Y. & Loeschcke, H.H. (1979). A cholinergic mechanism involved in the neuronal excitation by H+in the respiratory chemosensitive structures of the ventral medulla oblongata of rats in vitro. Pflugers Arch, 379, 125–135.CrossRefGoogle Scholar
  6. Gee, J.B.L. & Khandwala, A.S. (1977). Motility, transport and endocytosis in lung defense cells. In: Respiratory Defence MechanismsPart II. Ed. J. D. Brain, D. F. Proctor & L. M. Reid. Marcel Dekker Inc. New York, pp 926–981.Google Scholar
  7. Hirsh, K. & Wang, S.C. (1974). Selective respiratory stimulating action of doxapram compared to pentylenetetrazol. J. Pharmac. exp. Ther.189, 1–11.Google Scholar
  8. Hook, G.E.R. (1976). Pulmonary metabolism of xenobiotics. Life Sci., 18, 279–290.CrossRefGoogle Scholar
  9. Irivani, J. & Melville, G.N. (1981). Mucociliary function in the respiratory tract as influenced by physciochemical factors. In: Respiratory Pharmacology, Ed: J. Widdicombe. Pergamon Press, Oxford. pp 477–500.Google Scholar
  10. Jennett, S. (1976). Method of studying the control of breathing in experimental animals and man. Pharmac. Ther. B.2, 683–716.Google Scholar
  11. Jennett, S. (1982). Pulmonary function in the head injured patient. In: Head Injury and Anaesthesia. Ed. W. Fitch and J. Barker. In press. Elsevier/North Holland, Amsterdam.Google Scholar
  12. Laubie, M., Schmitt, H. (1980). Long-lasting hyperventilation induced by almitrine: evidence for a specific effect on carotid and thoracic chemoreceptors. Eur. J. Pharmac., 61, 125–136.CrossRefGoogle Scholar
  13. Moss, G., Staunton, C. & Stein, A. (1973). The centrineurogenic etiology of the acute respiratory distress syndromes. Amer. J. Surg., 126, 37–41.CrossRefGoogle Scholar
  14. Newsom Davis, J. (1970). Spinal control. In: The Respiratory Muscles. Ed. E. J. M. Campbell, E. Agostoni, J. Newsom Davis. Lloyd Luke, London. pp. 205–233.Google Scholar
  15. Paintal, A.S. (1973). Vagal sensory receptors and their reflex effects. Physiol. Rev., 53, 159–227.Google Scholar
  16. Piene, H. (1976). The influence of pulmonary blood flow rate on vascular input impedance and hydraulic power in the sympathetically and noradrenaline stimulated cat lung. Acta Physiol. Scand., 98, 44–53.CrossRefGoogle Scholar
  17. Richardson, P.S. & Phipps, R.J. (1981). The anatomy, physiology, pharmacology and pathology of tracheobronchial mucus secretion and the use of expectorant drugs in human disease. In: Respiratory Pharmacology. Ed. J. Widdicombe. Pergamon Press, Oxford. pp 437–475.Google Scholar
  18. Szidon, J.P. & Fishman, A.P. (1969). Autonomic control of the pulmonary circulation. In: A. P. Fishman and H. H. Hecht (Eds). The pulmonary circulation and interstitial space. Univ. Chicago Press, Chic. and London, pp.239–265.Google Scholar
  19. Vane, J.R. (1968). The alteration or removal of vasoactive substances by the pulmonary circulation. In: Importance of Fundamental Principles in Drug Evaluation. Raven Press, New York. pp. 217–235.Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Sheila Jennett
    • 1
  1. 1.Institute of PhysiologyUniversity of GlasgowScotlandUK

Personalised recommendations